EMA committee warns of small cardiovascular risk with high-dose ibuprofen.
London, UK – The Pharmacovingilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) is warning of an increased risk of cardiovascular events in patients who take high doses of the anti-inflammatory ibuprofen.
The committee, which began its review in 2014, states there is a small increase in the risk of MI and stroke with ibuprofen when taken at doses of 2400 mg/day or higher. The risk,
The full Post content is restricted to registered users. If you are an existing user, please log in. New users may register below.
NOTE: We do not sell, rent, share or loan any identifiable personal information to any third party.